NKTR
Nektar Therapeutics · Healthcare
President and CEO Howard W Robin sold $59K of Nektar Therapeutics
Sold$58,905
$3.00Price
19,635Shares
−2%Stake
What NKTR did after the filing
- The stock from Fri, Feb 17 close, $46.05
- −76.2%
- S&P 500, same days
- +1.3%
Measured over 30 trading days, to the Apr 3 close.
Traded Thu, Feb 16. Filed Fri, Feb 17, 3:57 PM ET, during the session. Returns use the Feb 17 close and the Apr 3 close. Not investment advice.